Kazia Therapeutics (KZIA) Income from Non-Controlling Interests (2009 - 2013)

Kazia Therapeutics has reported Income from Non-Controlling Interests for 5 years, with the latest figure at -$227195.6 in Q3 2013.

• For the quarter ending Q3 2013, Income from Non-Controlling Interests changed N/A year-over-year to -$227195.6; the trailing twelve-month figure through Jun 2012 stood at $1.7 million (up 716.27% YoY), and the FY2016 full-year result was -$67049.3, changed N/A from the prior year.
• Income from Non-Controlling Interests for Q3 2013 stood at -$227195.6, down from $2.8 million in the prior quarter.
• The five-year high for Income from Non-Controlling Interests was $3.9 million in Q2 2009, with the low at -$227195.6 in Q3 2013.
• Historically, Income from Non-Controlling Interests has averaged $1.7 million across 5 years, with a median of $1.7 million in 2012.
• Annual changes were most pronounced in 2011 — Income from Non-Controlling Interests tumbled 88.46% — and 2012, when it surged 716.27%.
• Kazia Therapeutics' Income from Non-Controlling Interests stood at $3.9 million in 2009, then plunged by 54.56% to $1.8 million in 2010, then plunged by 88.46% to $202781.6 in 2011, then soared by 1261.69% to $2.8 million in 2012, then tumbled by 108.23% to -$227195.6 in 2013.
• The last three Income from Non-Controlling Interests figures came in at -$227195.6 (Q3 2013), $2.8 million (Q4 2012), and $1.7 million (Q2 2012), per Business Quant data.